Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

High Tide

Market Cap: CA$281.2m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Cresco Labs

Market Cap: CA$504.1m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Bausch Health Companies

Market Cap: CA$1.8b

Operates as a diversified specialty pharmaceutical and medical device company.

Planet 13 Holdings

Market Cap: CA$60.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Aurora Cannabis

Market Cap: CA$239.7m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

Curaleaf Holdings

Market Cap: CA$3.5b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Jushi Holdings

Market Cap: CA$86.9m

Engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States.

MariMed

Market Cap: CA$26.2m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Medexus Pharmaceuticals

Market Cap: CA$160.5m

Operates as a pharmaceutical company in Canada and the United States.

Bright Minds Biosciences

Market Cap: CA$928.1m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Verano Holdings

Market Cap: CA$600.5m

Engages in the cannabis business in the United States.

Organigram Global

Market Cap: CA$196.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Rubicon Organics

Market Cap: CA$30.4m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

TerrAscend

Market Cap: CA$313.4m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Auxly Cannabis Group

Market Cap: CA$258.0m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

SOL Global Investments

Market Cap: CA$1.1m

A private equity firm specializing in emerging growth.

Avant Brands

Market Cap: CA$8.4m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Novartis

Market Cap: CA$232.1b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Vireo Growth

Market Cap: CA$643.5m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

Thermo Fisher Scientific

Market Cap: CA$192.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

1933 Industries

Market Cap: CA$2.6m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Gilead Sciences

Market Cap: CA$160.9b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Fennec Pharmaceuticals

Market Cap: CA$364.7m

Operates as a commercial stage biopharmaceutical company in the United States.

Pfizer

Market Cap: CA$135.2b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Roche Holding

Market Cap: CA$270.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Eli Lilly

Market Cap: CA$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

CordovaCann

Market Cap: CA$3.6m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Sanofi

Market Cap: CA$89.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Vext Science

Market Cap: CA$57.0m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Cybin

Market Cap: CA$373.8m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

SNDL

Market Cap: CA$338.4m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.

BioSyent

Market Cap: CA$166.7m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.